SANDERS MACHELLE - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 13, 2025, SANDERS MACHELLE's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Director, and currently has 30,642 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BCRX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SANDERS MACHELLE - Insider Non-Derivative Transactions of BCRX Common Stock

SANDERS MACHELLE - Insider Non-Derivative Transactions at BCRX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 14, 2025	Sell -- (Common Stock)	9600	7.14	30642
Jun 13, 2025	Acquisition -- (Common Stock)	12500	0	40242
Jun 18, 2024	Sell -- (Common Stock)	4689	6	27742
Jun 13, 2024	Acquisition -- (Common Stock)	6820	0	32431
Jun 16, 2023	Sell -- (Common Stock)	4000	7.98	25611
Jun 14, 2023	Acquisition -- (Common Stock)	16745	0	29611